Skip to content

Pfizer PFE Change in AP

Change in AP at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$409M+581%
Eli Lilly logo
Eli LillyLLY
$2.55B+290%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$3.92B-84.4%
Merck & Co. logo
Merck & Co.MRK
$27.5M-39.6%
Amgen logo
AmgenAMGN
$571M+14.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$3.1M+88.1%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$137.24B-0.4%
Enterprise value$199.91B+1.0%
P/E11.3×
P/S2.2×0.0×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.

The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's change in AP?
Pfizer (PFE) reported change in AP of -$117.25M in Q4 2025.
How has Pfizer's change in AP changed year-over-year?
Pfizer's change in AP increased by 54.2% year-over-year, from -$255.75M to -$117.25M.
What is the long-term trend for Pfizer's change in AP?
Over 4 years (2021 to 2025), Pfizer's change in AP has grown at a -21.6% compound annual growth rate (CAGR), from $1.24B to -$469M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.